Clinical Trials Browser

Phase 1 × Hematologic Neoplasms × Alemtuzumab × Clear all

NCT00113048 2014-02-05

Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies

Phase 1 Terminated

Other hematologic neoplasm

Hematologic Neoplasms

NCT00458250 2008-11-18

Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma